The company will offer its entire in vitro diagnostic product offerings through the medibuy marketplace. Customers will have access to prenegotiated contract pricing and real-time product availability information. The functionality is designed to streamline the procurement process for end users and enhance Roche’s service level to its customers.
Roche accompanies a growing list of medibuy suppliers serving a broad base of buyer relationships representing 42% of the acute care facilities in the US.
The decision to connect into medibuy’s marketplace enhances the richness and reach of data for both customer and supplier, voiced Martin Madaus, president and CEO of Roche Diagnostics Corp. Gains in efficiency, which up to this point have been inconceivable, are now a real possibility and will profoundly impact the supply chain.
We are proud to offer our buyers well recognized and respected brands in healthcare, expanded Dennis Murphy, president and CEO of medibuy in a company statement. As a leader in diagnostic healthcare products, we welcome Roche Diagnostics to our growing list of suppliers.
